Related Experiment Video
Updated: Jun 14, 2026

09:06
Intra-lymph Node Injection of Biodegradable Polymer Particles
Published on: January 2, 2014
14.5K
Injectable liposome-containing click hydrogel microparticles for release of macromolecular cargos
Luisa L Palmese1, Paige J LeValley2, Lina Pradhan2
1Materials Science and Engineering, University of Delaware, Newark, DE, USA. akloxin@udel.edu.
Soft Matter
|January 30, 2024
Summary
We developed injectable poly(ethylene) glycol (PEG)-based microgels and lipo-microgels using microfluidics. These microgels can encapsulate and sustain the release of therapeutic cargo for up to three weeks.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Microfluidics
Background:
- Hydrogel microparticles (microgels) offer advantages for biological applications due to their injectability and modularity.
- Existing methods for microgel production require expansion to meet diverse therapeutic needs.
Purpose of the Study:
- To establish a microfluidic method for producing poly(ethylene) glycol (PEG)-based microgels and liposomes-containing microgels (lipo-microgels).
- To characterize the physicochemical properties and cargo delivery capabilities of the developed microgels.
Main Methods:
- Droplet-based microfluidics was employed to synthesize PEG-based microgels and lipo-microgels via Michael-type addition reactions.
- Microgel size, morphology, liposome presence, mechanical properties (AFM), and cargo release kinetics were analyzed.
Main Results:
- Uniform spherical microgels (74 ± 16 μm) and lipo-microgels (82 ± 25 μm) were successfully produced, confirmed by microscopy.
- Rheological analysis supported the injectability of the microgels.
- Sustained release of model cargo (FITC-Dextran 5 kDa) and protein (equine myoglobin) was observed for up to 3 weeks, with preserved protein structure.
Conclusions:
- The microfluidic method provides a versatile platform for creating injectable PEG-based microgels and lipo-microgels.
- These microgels demonstrate potential for protecting and controlling the release of therapeutic cargos, including proteins.
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

